PREŠOVSKÁ UNIVERZITA V PREŠOVE
UNIVERZITNÁ KNIŽNICA
UNIVERZITNÁ KNIŽNICA
| ID záznamu: | 146885 |
|---|---|
| Kategória: | ADC |
| Autor: | Kappos Ludwig (0%) |
| Autor: | Bar-Or Amit (0%) |
| Autor: | Cree Bruce A. C. (0%) |
| Autor: | Fox Robert J. (0%) |
| Autor: | Giovannoni Gavin (0%) |
| Autor: | Klímová Eleonóra (0%) |
| Názov: | Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study [print, elektronický dokument] |
| Zdroj: | The Lancet [print, elektronický dokument] : a journal of British and foreign medicine, surgery, obstetrics, physiology, chemistry, pharmacology, public health and news |
| Lokácia: | Roč. 391, č. 10127. - New York : Elsevier, (2018), s. 1263-1273 |
| ISSN: | 0140-6736. - ISSN 1474-547X |
| Ohlas: | [1] 2018. MAILLART, Elisabeth. Treatment of progressive multiple sclerosis: Challenges and promising perspectives. In Revue neurologique : print, ISSN 0035-3787; 2213-0004. 2018, Roč. 174, č. 6, 441-448. |
| Ohlas: | [1] 2018. EPSTEIN, David J., DUNN, Jeffrey, DERESINSKI, Stan. Infectious complications of multiple sclerosis therapies: Implications for screening, prophylaxis, and management. In Open Forum Infectious Diseases : elektronický dokument, ISSN 2328-8957. Cary, NC, 2018, Roč. 5, č. 8. |
| Ohlas: | [1] 2019. GARDIN, Anne, UFER, Mike, LEGANGNEUX, Eric et al. Effect of Fluconazole Coadministration and CYP2C9 Genetic Polymorphism on Siponimod Pharmacokinetics in Healthy Subjects. In Clinical pharmacokinetics : print, elektronický dokument, ISSN 0312-5963; 1179-1926. 2019, Roč. 58, č. 3, 349-361. |
| Ohlas: | [1] 2018. GRANDMAISON, Francois, YEUNG, Michael, MORROW, Sarah et al. Sequencing of high-efficacy disease-modifying therapies in multiple sclerosis: Perspectives and approaches. In Neural Regeneration Research : print, ISSN 1673-5374; 1876-7958. 2018, Roč. 13, č. 11, 1871-1874. |
| Ohlas: | [1] 2018. MCGINLEY, Marisa, FOX, Robert J. Prospects of siponimod in secondary progressive multiple sclerosis. In Therapeutic Advances in Neurological Disorders : print, elektronický dokument, ISSN 1756-2856; 1756-2864. London, 2018, Roč. 11. |
| Ohlas: | [1] 2018. GLAENZEL, Ulrike, JIN, Yi, NUFER, Robert et al. Metabolism and disposition of siponimod, a novel selective S1P<inf>1</inf>/S1P<inf>5</inf> agonist, in healthy volunteers and in vitro identification of human cytochrome P450 enzymes involved in its oxidative metabolism. In Drug Metabolism and Disposition : print, elektronický dokument, ISSN 0090-9556; 1521-009X. 2018, Roč. 46, č. 7, 1001-1013. |
| Ohlas: | [1] 2019. DIXIT, Dhaval, OKUNIEWSKA, Martyna, SCHWAB, Susan R. Secrets and lyase: Control of sphingosine 1-phosphate distribution. In Immunological reviews : print, elektronický dokument, ISSN 0105-2896; 1600-065X. Oxford, 2019, Roč. 289, č. 1, 173-185. |
| Ohlas: | [1] 2018. YAMOUT, Bassem I., ALROUGHANI, Raed. Multiple Sclerosis. In Seminars in Neurology : print, ISSN 0271-8235; 1098-9021. 2018, Roč. 38, č. 2, 212-225. |
| Ohlas: | [1] 2019. VAUGHN, Caila B., JAKIMOVSKI, Dejan, KAVAK, Katelyn S. et al. Epidemiology and treatment of multiple sclerosis in elderly populations. In Nature Reviews Neurology : print, elektronický dokument, ISSN 1759-4758; 1759-4766. 2019, Roč. 15, č. 6, 329-342. |
| Ohlas: | [1] 2018. CONNICK, Peter, DE ANGELIS, Floriana, PARKER, Richard A. et al. Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial (MS-SMART): A multiarm phase IIb randomised, double-blind, placebo-controlled clinical trial comparing the efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis. In BMJ open : elektronický dokument, ISSN 2044-6055. Londýn, 2018, Roč. 8, č. 8. |
| Ohlas: | [1] 2018. KÜRY, Patrick, KREMER, David, GÖTTLE, Peter. Drug repurposing for neuroregeneration in multiple sclerosis. In Neural Regeneration Research : print, ISSN 1673-5374; 1876-7958. 2018, Roč. 13, č. 8, 1366-1367. |
| Ohlas: | [1] 2020. CHATAWAY, Jeremy, DE ANGELIS, Floriana, CONNICK, Peter et al. Efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis (MS-SMART): a phase 2b, multiarm, double-blind, randomised placebo-controlled trial [elektronický dokument]. In The Lancet Neurology : print, ISSN 1474-4422. Oxford, 2020, Roč. 19, č. 3, s. 214-225. |
| Ohlas: | [1] 2020. ENDERS, Michael, HEIDER, Thorsten, LUDWIG, Andreas et al. Strategies for neuroprotection in multiple sclerosis and the role of calcium [elektronický dokument]. In International journal of molecular sciences : print, elektronický dokument, ISSN 1422-0067; 1661-6596. Bazilej, 2020, Roč. 21, č. 5, s. 1663-1663. CCC; SCO; WOS CC. |
| Ohlas: | [1] 2020. WU, Qi, MILLS, Elizabeth A., WANG, Q, Qin et al. Siponimod enriches regulatory T and B lymphocytes in secondary progressive multiple sclerosis [elektronický dokument]. In JCI Insight : elektronický dokument, ISSN 2379-3708. 2020, Roč. 5, č. 3, s. 1-14. |
| Ohlas: | [1] 2020. SANDBORN, William J., PEYRIN-BIROULET, Laurent, ZHANG, Jinkun et al. Efficacy and safety of etrasimod in a phase 2 randomized trial of patients with ulcerative colitis [elektronický dokument]. In Gastroenterology : print, elektronický dokument, ISSN 0016-5085; 1528-0012. Washington, 2020, Roč. 158, č. 3, s. 550-561. |
| Ohlas: | [1] 2020. SHARRACK, Basil, SACCARDI, Riccardo, ALEXANDER, Tobias et al. Autologous haematopoietic stem cell transplantation and other cellular therapy in multiple sclerosis and immune-mediated neurological diseases: updated guidelines and recommendations from the EBMT Autoimmune Diseases Working Party (ADWP) and the Joint Accreditation Committee of EBMT and ISCT (JACIE) [elektronický dokument]. In Bone marrow transplantation : print, elektronický dokument, ISSN 0268-3369; 1476-5365. Londýn, 2020, Roč. 55, č. 2, s. 283-306. |
| Ohlas: | [1] 2020. CHALMER, Thor, BURON, Mathias, ILLES, Zsolt et al. Clinically stable disease is associated with a lower risk of both income loss and disability pension for patients with multiple sclerosis [elektronický dokument]. In Journal of neurology, neurosurgery and psychiatry : print, elektronický dokument, ISSN 0022-3050; 1468-330X. Londýn, 2020, Roč. 91, č. 1, s. 67-74. |
| Ohlas: | [1] 2020. MIMPEN, Max, SMOLDERS, Joost, HUPPERTS, Raymond M.M. et al. Natural killer cells in multiple sclerosis: a review [elektronický dokument]. In Immunology Letters : print, ISSN 0165-2478; 1879-0542. Amsterdam, 2020, Roč. 222, s. 1-11. |
| Ohlas: | [1] 2020. COLOMBO, Emanuela, BASSANI, Claudia, DE ANGELIS, Anthea et al. Siponimod (BAF312) activates Nrf2 while hampering NFκB in human astrocytes, and protects from astrocyte-induced neurodegeneration [elektronický dokument]. In Frontiers in Immunology : elektronický dokument, ISSN 1664-3224. Lausanne, 2020, Roč. 11. SCO. |
| Ohlas: | [1] 2020. CIOTTI, John, SANDERS, Noah, SALTER, Amber R. et al. Clinical instrument to retrospectively capture levels of EDSS [elektronický dokument]. In Multiple sclerosis and related disorders : elektronický dokument, print, ISSN 2211-0348; 2211-0356. Oxon, 2020, č. 39, s. 1-8. SCO ; WOS CC. |
| Ohlas: | [1] 2020. HEALY, Luke M., YAQUBI, Moein, LUDWIN, Samuel K. et al. Species differences in immune-mediated CNS tissue injury and repair: a (neuro)inflammatory topic [elektronický dokument]. In GLIA : elektronický dokument, print, ISSN 08941491; 1098-1136. New York, 2020, Roč. 68, č. 4, s. 811-829. |
| Ohlas: | [1] 2020. ONTANEDA, Daniel, TALLANTYRE, Emma, RAZA, Praneeta C. et al. Determining the effectiveness of early intensive versus escalation approaches for the treatment of relapsing-remitting multiple sclerosis: the DELIVER-MS study protocol [elektronický dokument]. In Contemporary clinical trials : print, elektronický dokument, ISSN 1551-7144; 1559-2030. New York, 2020, Roč. 95, s. 1-10. SCO. |
| Ohlas: | [1] 2020. SAMJOO, Imtiaz A., WORTHINGTON, Evelyn, HALTNER, Anja et al. Matching-adjusted indirect treatment comparison of siponimod and other disease modifying treatments in secondary progressive multiple sclerosis [elektronický dokument]. In Current Medical Research and Opinion : print, ISSN 0300-7995; 1473-4877. Londýn, 2020, Roč. 36, č. 7, s. 1157-1166. CCC ; SCO ; WOS CC. |
| Ohlas: | [1] 2020. SAMJOO, Imtiaz A., WORTHINGTON, Evelyn, HALTNER, Anja et al. The importance of considering differences in study and patient characteristics before undertaking indirect treatment comparisons: a case study of siponimod for secondary progressive multiple sclerosis [elektronický dokument]. In Current Medical Research and Opinion : print, ISSN 0300-7995; 1473-4877. Londýn, 2020, Roč. 36, č. 7, s. 1145-1156. CCC ; SCO ; WOS CC. |
| Ohlas: | [1] 2020. SOTIRCHOS, Elias S., GONZALEZ-CALDITO, Natalia, FILIPPATOU, Angeliki G. et al. Progressive multiple sclerosis Is associated with faster and specific retinal layer atrophy [elektronický dokument]. In Annals of Neurology : print, ISSN 0364-5134; 1531-8249. Hoboken, 2020, Roč. 87, č. 6, s. 885-896. |
| Ohlas: | [1] 2020. PAOLICELLI, Damiano, MANNI, Alessia, IAFFALDANO, Antonio et al. Efficacy and safety of oral therapies for relapsing-remitting multiple sclerosis [elektronický dokument]. In CNS Drugs : print, ISSN 1172-7047; 1172-7049; 1179-1934. 2020, Roč. 34, č. 1, s. 65-92. |
| Ohlas: | [1] 2019. GARDIN, Anne, SHAKERI-NEJAD, Kasra, FELLER, Andrea et al. Siponimod pharmacokinetics, safety, and tolerability in combination with the potent CYP3A4 inhibitor itraconazole in healthy subjects with different CYP2C9 genotypes. In European journal of clinical pharmacology : print, elektronický dokument, ISSN 0031-6970; 1432-1041. Heidelberg, 2019, Roč. 75, č. 11, s. 1565-1574. |
| Ohlas: | [1] 2021. SCHWEITZER, F., LAURENT, S., FINK, G.R. Effects of disease-modifying therapy on peripheral leukocytes in patients with multiple sclerosis. In Journal of neurology, ISSN 0340-5354. 2021, roč. 268, č. 7, s. 2379-2389. WOS:000515966700001; SCOPUS. |
| Ohlas: | [1] 2020. MEI, H., REMETE, A.M., ZOU, Y. et al. Fluorine-containing drugs approved by the FDA in 2019. In Chinese chemical letters, ISSN 1001-8417. 2020, roč. 31, č. 9, s. 2401-2413. WOS:000582384200040; SCOPUS. |
| Oblasť výskumu: | 180 |
